Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-Tacrolimus vs Daclizumab-Tacrolimus-Mycophenolate in Kidney Transplantation
NCT00246129Phase 4Completed
- Sponsor
- Magnusson
- Start
- Oct 2005
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of alemtuzumab in kidney transplantation, sponsored by Magnusson. Started Oct 2005; status: completed.
02
Drugs
alemtuzumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00246129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246129.